Detalhe da pesquisa
1.
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.
Lancet Oncol
; 25(1): 99-107, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38043558
2.
177Lu-Prostate-specific Membrane Antigen Radioligand Therapy in Patients with Metastatic Castration-resistant Prostate Cancer.
Radiology
; 306(2): e220859, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36125377
3.
FDG PET/CT Prognostic Markers in Patients with Advanced Melanoma Treated with Ipilimumab and Nivolumab.
Radiology
; 307(3): e221180, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36853183
4.
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging
; 50(9): 2830-2845, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37246997
5.
Integrating Theranostics Into Patient Care Pathways: AJR Expert Panel Narrative Review.
AJR Am J Roentgenol
; 220(5): 619-629, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36321986
6.
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial.
Lancet Oncol
; 23(11): 1389-1397, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36261050
7.
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
Lancet
; 397(10276): 797-804, 2021 02 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33581798
8.
Failure modes and effects analysis of pediatric I-131 MIBG therapy: Program design and potential pitfalls.
Pediatr Blood Cancer
; 69(12): e29996, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36102748
9.
Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response-AJR Expert Panel Narrative Review.
AJR Am J Roentgenol
; 218(5): 767-780, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34985313
10.
Myocardial uptake of 68Ga-DOTATATE: correlation with cardiac disease and risk factors.
Acta Radiol
; 63(9): 1166-1172, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34713716
11.
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Lancet
; 395(10231): 1208-1216, 2020 04 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32209449
12.
Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 48(1): 204-216, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32572559
13.
Utility of 68 Ga-DOTA-Exendin-4 positron emission tomography-computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endogenous hyperinsulinaemic hypoglycaemia.
Intern Med J
; 51(10): 1657-1664, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-33314504
14.
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617.
Eur J Nucl Med Mol Imaging
; 47(10): 2322-2327, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32140802
15.
FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment.
Eur J Nucl Med Mol Imaging
; 47(12): 2776-2786, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32338306
16.
PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment.
Eur J Nucl Med Mol Imaging
; 46(9): 1869-1877, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31190177
17.
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series.
Eur J Nucl Med Mol Imaging
; 46(9): 1902-1910, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31187162
18.
Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study.
Eur J Nucl Med Mol Imaging
; 46(8): 1596-1604, 2019 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-31044265
19.
TheraP: a randomized phase 2 trial of 177 Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603).
BJU Int
; 124 Suppl 1: 5-13, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31638341
20.
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.
Lancet Oncol
; 19(6): 825-833, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29752180